PATENT CLAIM ANALYSIS

Application Number: 16199739
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "259300"]

Abstract:
A liquid formulation of (S)—N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, pharmaceutically acceptable salts thereof, or a combination thereof and the use of the liquid formulation in the treatment of pain, cancer, inflammation, and certain infectious diseases are disclosed.

Claim (Index 18):
The liquid formulation of  claim 1 , wherein the liquid formulation further comprises potassium sorbate.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 98.0
- Lexical Diversity: 1.4878
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15622544', '15622388', '15861017', '15872769', '15399207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7258514539408027
- 35 USC 102 Novelty (BERT): 0.5839710988169918
- Combined Prediction Score: 0.7116634184284217
- Mean Citation Score: 449.37463400000007
- Max Citation Score: 551.3446
- Similarity Product: 358.2493286374927

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test